StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report released on Sunday morning. The firm issued a sell rating on the stock.
Navidea Biopharmaceuticals Price Performance
Shares of Navidea Biopharmaceuticals stock opened at $0.00 on Friday. Navidea Biopharmaceuticals has a 52 week low of $0.00 and a 52 week high of $0.13.
About Navidea Biopharmaceuticals
Want More Great Investing Ideas?
Featured Articles
- Five stocks we like better than Navidea Biopharmaceuticals
- What Are Some of the Best Large-Cap Stocks to Buy?
- MP Materials: Rare Earth Elements Powering the EV Boom
- How to Calculate Stock Profit
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- Canadian Penny Stocks: Can They Make You Rich?
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for Navidea Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Navidea Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.